Home › Obesità › Florida › Hialeah
Studi clinici su Obesità a Hialeah, FL
13 studi su Obesità cercano partecipanti presso sedi a Hialeah e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
In reclutamentoFase 2
- AGA Clinical Trials, Hialeah
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
In reclutamentoFase 3
- Miguel Rebollar PA, Hialeah
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
In reclutamentoFase 3
- Elite Cardiac Research Center LLC, Hialeah
- Elite Clinical Research, Hialeah
- Panax Clinical Research, Miami Lakes · a 4 mi di distanza
- e altri 2
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
In reclutamentoFase 2
- Indago Research & Health Center, Inc, Miami Lakes · a 4 mi di distanza
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
In reclutamentoFase 3
- Elite Cardiac Research Center LLC, Hialeah
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
In reclutamentoFase 2
- Indago Research & Health Center, Inc, Miami Lakes · a 4 mi di distanza
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
In reclutamentoFase 4
- NeoClinical Research, Hialeah
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
In reclutamentoFase 3
- Kailera Clinical Site, Miami Lakes · a 4 mi di distanza
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
In reclutamentoFase 3
- Indago Research and Health Center, Miami Lakes · a 4 mi di distanza
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
In reclutamentoFase 3
- San Marcus Research Clinic Inc, Miami Lakes · a 4 mi di distanza
- Indago Research and Health Center, Miami Lakes · a 4 mi di distanza
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
In reclutamentoFase 3
- Aga Clinical Trials, Hialeah
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
In reclutamentoFase 3
- Inpatient Research Clinic LLC, Miami Lakes · a 4 mi di distanza
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
In reclutamentoFase 3
- Angels Clinical Research Institute, Miami Lakes · a 4 mi di distanza
Studi su Obesità in altre città
- Houston, TX43 studi
- Chicago, IL41 studi
- New York City, NY40 studi
- San Antonio, TX40 studi
- Washington, DC33 studi
- Orlando, FL31 studi
- Dallas, TX30 studi
- Boston, MA28 studi
- Las Vegas, NV27 studi
- Miami, FL27 studi
- Baltimore, MD25 studi
- Jacksonville, FL25 studi
Altri studi a Hialeah
- Schizofrenia13 studi
- Insufficienza cardiaca12 studi
- Diabete di tipo 210 studi
- Sovrappeso10 studi
- Malattia epatica steatosica9 studi
- BPCO8 studi
- Disturbo depressivo maggiore8 studi
- Aterosclerosi8 studi
- Morbo di Alzheimer6 studi
- Condizioni post-COVID (Long COVID)6 studi
- Cancro (tutti i tipi)6 studi
- Malattie cardiovascolari6 studi
Fonte: ClinicalTrials.gov, dati recuperati il 3 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.